Leerink Defending Raptor Pharma, Would Buy On Today's Weakness

By: via Benzinga
Encouraged by mgmt decision to not invest further in NAFLD, sees better opportunity for company to make strong case for RP103
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.